ARDT

Ardent Health Partners, LLC (ARDT) 10Y Growth Potential Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Growth Durability

Revenue base remains supported by a low EV/Sales multiple of 0.49, suggesting the market is still pricing in limited long-term growth.

Profitability is modest, with net margin at 1.2% and operating margin at 7.5%, which limits confidence in sustained high-growth compounding.

Return on invested capital is 9.3%, indicating the business can earn acceptable returns on capital but not yet at a clearly exceptional level.

Financial Strength

Liquidity is solid with a current ratio of 2.10 and quick ratio of 1.99, giving the company room to absorb volatility.

Leverage remains meaningful, with debt-to-equity at 1.68 and net debt to EBITDA at 3.84, which constrains flexibility.

Interest coverage of 9.7x and debt service coverage of 4.6x suggest the balance sheet is manageable despite the leverage load.

Cash Flow Quality

Free cash flow generation is strong, with a 19.2% free cash flow yield and free cash flow to firm of 340.8M.

Cash conversion is healthy, as the cash conversion cycle is only 14.1 days and operating cash flow covers capital spending by 2.4x.

Income quality is mixed at 3.54, implying earnings are not fully backed by accounting quality even though cash generation is solid.

Capital Efficiency

Return on equity is 5.2% and return on assets is 1.5%, indicating only modest efficiency in turning capital into profits.

Return on capital employed of 11.2% is better than ROE/ROA and suggests the core business is generating acceptable operating returns.

Asset turnover of 1.21x and operating asset returns remain decent, but not strong enough to support a high-conviction long-term compounding case.

Valuation

Valuation looks reasonable, with EV/Sales at 0.49 and price-to-free-cash-flow at 5.2x.

Price-to-book of 1.15x and price-to-sales of 0.24x indicate the market is not assigning a premium multiple.

The low earnings yield of 5.0% tempers the attractiveness somewhat, but the overall setup still appears undemanding.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Ardent Health Partners, LLC. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →